相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients
Theodora Pappa et al.
CLINICAL CANCER RESEARCH (2021)
Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways
Yimin Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
The Prognostic Value of MicroRNAs in Thyroid Cancers-A Systematic Review and Meta-Analysis
Cristina Alina Silaghi et al.
CANCERS (2020)
Clinical Development of BRAF plus MEK Inhibitor Combinations
Vivek Subbiah et al.
TRENDS IN CANCER (2020)
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies
Inigo Landa et al.
CLINICAL CANCER RESEARCH (2019)
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Maria E. Cabanillas et al.
ENDOCRINE REVIEWS (2019)
Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma
Jun Han et al.
SCIENTIFIC REPORTS (2018)
Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF
W. Imruetaicharoenchoke et al.
ENDOCRINE-RELATED CANCER (2017)
MicroRNA-based molecular classification of papillary thyroid carcinoma
Francesca Rosignolo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis
Shujun Xia et al.
ONCOTARGETS AND THERAPY (2017)
MicroRNA in diagnostics and therapy of thyroid cancer
Anna Wojcicka et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells
Hao Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1
Xinfeng Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells
Marialuisa Sponziello et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers
Manuel Saiselet et al.
ONCOTARGET (2016)
Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validation
Yiren Hu et al.
CANCER MEDICINE (2016)
Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer
Chen-min Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2016)
Integrin α3β1 Binding to Fibronectin Is Dependent on the Ninth Type III Repeat
Ashley C. Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Focal adhesion signaling and therapy resistance in cancer
Iris Eke et al.
SEMINARS IN CANCER BIOLOGY (2015)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer
L. Zhou et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Guidelines for the management of thyroid cancer
Petros Perros et al.
CLINICAL ENDOCRINOLOGY (2014)
Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib
Ramona Dadu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications
Andy Rimmer et al.
NATURE GENETICS (2014)
Patterns of Structural Recurrence in Papillary Thyroid Cancer
Schelto Kruijff et al.
WORLD JOURNAL OF SURGERY (2014)
DICER1: mutations, microRNAs and mechanisms
William D. Foulkes et al.
NATURE REVIEWS CANCER (2014)
Suppression, subversion and escape: the role of regulatory T cells in cancer progression
K. Oleinika et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Metastatic mechanisms in follicular cell-derived thyroid cancer
John E. Phay et al.
ENDOCRINE-RELATED CANCER (2013)
Manipulation of PBF/PTTG1IP Phosphorylation Status; a Potential New Therapeutic Strategy for Improving Radioiodine Uptake in Thyroid and Other Tumors
V. E. Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effect of reoperation on outcomes in papillary thyroid cancer
Stephanie Young et al.
SURGERY (2013)
Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence
David Paez et al.
CLINICAL CANCER RESEARCH (2012)
Programmed Death-1+ T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer
Jena D. French et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
SIFT web server: predicting effects of amino acid substitutions on proteins
Ngak-Leng Sim et al.
NUCLEIC ACIDS RESEARCH (2012)
FN1, GALE, MET, and QPCT Overexpression in Papillary Thyroid Carcinoma: Molecular Analysis Using Frozen Tissue and Routine Fine-Needle Aspiration Biopsy Samples
Cristina Aparecida Troques da Silveira Mitteldorf et al.
DIAGNOSTIC CYTOPATHOLOGY (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
Metastatic Dormancy and Progression in Thyroid Cancer: Targeting Cells in the Metastatic Frontier
Matthew D. Ringel
THYROID (2011)
MutationTaster evaluates disease-causing potential of sequence alterations
Jana Marie Schwarz et al.
NATURE METHODS (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
B-RafV600E and thrombospondin-1 promote thyroid cancer progression
Carmelo Nucera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer
Vicki E. Smith et al.
JOURNAL OF CELL SCIENCE (2009)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper et al.
THYROID (2009)
Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples
Franclim Ricardo Ribeiro et al.
BMC CANCER (2008)
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
Rebecca E. Schweppe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models
Jia-Jing Lee et al.
THYROID (2007)
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
BR Smith et al.
THYROID (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Oncofoetal fibronectin - a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma
E Hesse et al.
BRITISH JOURNAL OF CANCER (2005)
分享论文
